NCT02804386View on ClinicalTrials.gov

Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon

PHASE4CompletedINTERVENTIONAL

Enrollment

573

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

January 30, 2018

Conditions

Hepatitis C, Chronic

Interventions

DRUG

Sofosbuvir

Sofosbuvir (formerly known as GS-7977) is a direct-acting nucleotide polymerase inhibitor that is being developed as an oral drug for the treatment of chronic HCV infection

Trial Locations (1)

Unknown

Ojha, Duhs, Karachi

All Listed Sponsors

lead

PharmEvo Pvt Ltd

INDUSTRY

NCT02804386 - Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon | Biotech Hunter | Biotech Hunter